Skip to main content

Use of Combined Monoclonal Antibodies for the Immunochemical Determination of Apolipoproteins A–I and B in Human Plasma

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 210))

Abstract

Plasma cholesterol level Is a risk factor for the development of coronary artery disease (1). Indeed, the cholesterol bound to low-density lipoprotein (LDL) appears to better correlate with the risk of coronary heart disease (CHD) as compared to plasma cholesterol levels while the cholesterol bound to high-density lipoprotein (HDL) is inversely related to the risk of developing CHD.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goldstein JL, Brown MS. Familial hypercholesterolemia. In Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. New York, 672–712 (1983).

    Google Scholar 

  2. Avogaro P, Bittolo Bon G, Cazzolato G, Quinci GB, Belussi F. Plasma level of lipoprotein A-I and apolipoprotein B in human atherosclerosis. Artery 4, 385–394 (1978).

    Google Scholar 

  3. Riesen WF, Mordasini R, Salzmann C, Theler A., Gurtner HP. Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis 37, 157–162 (1980).

    Article  PubMed  CAS  Google Scholar 

  4. De Backer G, Rosseneu M, Deslypere JP. Discriminative value of lipids and apoproteins in coronary heart disease. Atherosclerosis 42, 197–203 (1982).

    Article  PubMed  Google Scholar 

  5. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibodies of predifined specificity. Nature 256, 495–497 (1975).

    Article  PubMed  Google Scholar 

  6. Tsao BP, Curtiss LK, Edgington TS. Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins. J Biol Chem 257, 15222–15228 (1982).

    PubMed  CAS  Google Scholar 

  7. Marcovina S, France D, Phillips RA, Mao SJT. Monoclonal antibodies can precipitate low-density lipoprotein. I. Characterization and use in determining apolipoprotein B. Clin Chem 31, 1654–1658 (1985).

    PubMed  CAS  Google Scholar 

  8. Curtiss LK, Edgington TS. Immunochemical heterogeneity of human plasma high density lipoproteins. Identification with apolipoprotein A-I and A-II specific monoclonal antibodies. J Biol Chem 260, 2982–2993 (1985).

    PubMed  CAS  Google Scholar 

  9. Marcovina S, Kottke BA, Mao SJT. Monoclonal antibodies can precipitate low density lipoprotein. II. Radioimmunoassay with single and combined monoclonal antibodies for determining apolipoprotein B in serum of patients with coronary artery disease. Clin Chem 31, 1659–1663 (1985).

    PubMed  CAS  Google Scholar 

  10. Marcovina S, Di Cola G, Rapetto C, et al. Development of a radial immunodiffusion technique employing monoclonal antibodies for apolipoprotein B determination in human plasma. Clin Chim Acta 147, 117–125 (1985).

    Article  PubMed  CAS  Google Scholar 

  11. Marcovina S, Price PJ, McDougal JS, Cremonesi L. Monoclonal antibodies directed against human low density lipoprotein and their characterization by the immunodot technique. Protides Biological Fluids Proc Colloq 31, 985–989 (1984).

    Google Scholar 

  12. Scanu AM, Edelstein C. Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins. Relevance to the recovery problem during delipidation of serum lipoproteins. Analyt Biochem 53, 576–588 (1973).

    Google Scholar 

  13. Egusa G, Brady DW, Grundy SM, Howard BV. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentration during metabolic studies of very low density lipoprotein apolipoprotein B. J Lip Res 24, 1261–1267 (1983).

    CAS  Google Scholar 

  14. Markwell MAK, Haas SM, Bieber LL, Toebert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87, 206–210 (1978).

    Article  PubMed  CAS  Google Scholar 

  15. Wayne TF, Alaupovic P, Curry MD, et al. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis 39, 411–424 (1981).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Press, New York

About this chapter

Cite this chapter

Marcovina, S., Catapano, A.L. (1987). Use of Combined Monoclonal Antibodies for the Immunochemical Determination of Apolipoproteins A–I and B in Human Plasma. In: Malmendier, C.L., Alaupovic, P. (eds) Lipoproteins and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 210. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1268-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1268-0_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1270-3

  • Online ISBN: 978-1-4684-1268-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics